Guide: A Strategic Framework for U.S. Implementation
Comprehensive Guide to Expanded Access Program Success
Expanded Access, often referred to as Compassionate Use, is a pathway established by U.S. Food and Drug Administration (FDA) regulations. This program allows patients with immediately life-threatening diseases to access investigational therapies or medical devices that have not yet received full FDA approval.